Neulife, a Mumbai-based performance nutrition and protein innovation company, has raised $1 million in seed funding, co-led by Subhkam Ventures and Singularity Ventures, with participation from Sunicon Ventures, Cosma Ventures, and select high-net-worth individuals (HNIs).
This marks Neulife’s first external funding since its inception in 2014. The proceeds will be used to develop new products, expand clinical research, and scale its protein portfolio. The company also plans to invest part of the capital to accelerate global expansion and strengthen its R&D infrastructure.
Founded by Samit Gupta, Neulife operates as an R&D-led performance nutrition brand built around scientifically validated formulations and metabolically efficient protein systems. The company launched its direct-to-consumer (D2C) business in 2022, leveraging its patented Ketofuel MCT technology to design high-absorption protein supplements.
Science-Driven Nutrition Innovation
Neulife’s flagship products include Pro Standard Whey (launched in 2023) and Super Isolate (launched in 2024). Both products claim to deliver 30% higher protein absorption and efficiency compared to conventional whey and plant-based proteins.
With five patents filed—two granted and three pending—Neulife continues to invest heavily in clinical trials and metabolic performance studies to back its formulations with scientific data.
The company aims to capture 15% of India’s premium protein supplement market by 2028, targeting professional athletes and serious fitness enthusiasts. It also plans to raise an additional $3 million by end-2026 to fund new product development and global expansion across Southeast Asia and the Middle East.
Currently, Neulife’s products are sold through its website and major online marketplaces, including Amazon and Flipkart, catering to India’s growing demand for science-backed performance nutrition.
By: Arushi Agarwal
